100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
CSO EXAM PREP LATEST 2024 UPDATE WITH MULTIPLE, HIGHLY PREDICTED QUESTIONS WITH COMPLETE SOLUTIONS $11.49   Add to cart

Exam (elaborations)

CSO EXAM PREP LATEST 2024 UPDATE WITH MULTIPLE, HIGHLY PREDICTED QUESTIONS WITH COMPLETE SOLUTIONS

 6 views  0 purchase

CSO EXAM PREP LATEST 2024 UPDATE WITH MULTIPLE, HIGHLY PREDICTED QUESTIONS WITH COMPLETE SOLUTIONS

Preview 4 out of 33  pages

  • October 9, 2024
  • 33
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
All documents for this subject (69)
avatar-seller
bonie314
CSO EXAM PREP LATEST 2024 UPDATE WITH MULTIPLE,

HIGHLY PREDICTED QUESTIONS WITH CORRECT

SOLUTIONS GRADED A+




A dcancer dpatient dis dfully dactive dand dable dto dcarry don dall dpre-disease
dactivities dwithout drestrictions. dWhich dEastern dCooperative dOncology

dGroup d(ECOG) dgrade dis dappropriate?



A. dGrade d0

B. dGrade d1

C. dGrade d2

D. dGrade d3 d d d d d d d d dANSWER: d✔- dA. dGrade d0 dis dfully dactive dand dable
dto dcarry don dall dpre-disease dactivities dwithout drestrictions. d



(KS d90-100)



A dcancer dpatient dis dunable dto dprovide dself-care. dHis ddisease dis
dprogressing drapidly dand dprognosis dis dpoor. dWhich dnumber dlikely

drepresents dhis dKarnofsky dPerformance dStatus?

,A. d100

B. d70

C. d40

D. d0 d d d d d d d d dANSWER: d✔- dC. d40

Disabled; drequires dspecial dcare d& dassistance.

0 d- dDEAD

100 d- dno devidence dof ddisease



A dpatient dwith dnewly ddiagnosed dpancreatic dcancer dcompletes dthe
dScored dPatient-Generated dSubjective dGlobal dAssessment d(PG-SGA©)

dwith dinformation dregarding dweight, dfood dintake, dsymptoms dand

dactivities/functional dstatus. dThe dadditive dscore dis d10. dWhat ddoes dthis

dscore dmean?



A. dNo dintervention dis drequired dat dthis dtime.

B. dRequires dintervention dby dRD dwith dRN dor dMD

C. dIndicates da dcritical dneed dfor dimproved dsymptom dmanagement d&/or
dnutrient dintervention doptions d d d d d d d d dANSWER: d✔- d>/= d9 dIndicates da

dcritical dneed dfor dimproved dsymptom dmanagement d&/or dnutrient

dintervention doptions




An doral dprodrug dthat dis dconverted dto d5-FU din dthe dbody d d d d d d d d
dANSWER: d✔- dcapecitabine d(Xeloda)

,Anticipatory dnausea dand dvomiting d(ANV) d d d d d d d d dANSWER: d✔-
dAnticipatory dnausea dand dvomiting d(ANV), dalso dis dwidely dbelieved dto

dbe da dlearned dresponse dto dchemotherapy dthat d25% dof dpatients

ddevelop dby dthe d4th dtreatment dcycle




Avoid dholding dEN dfor dgastric dresidual dvolumes dof d<__________ dmL din
dthe dabsence dof dother dsigns dof dintolerance d d d d d d d d dANSWER: d✔- dAvoid

dholding dEN dfor dgastric dresidual dvolumes dof d<500mL din dthe dabsence

dof dother dsigns dof dintolerance




Biotherapy dis da dtreatment dto d... d d d d d d d d dANSWER: d✔- dBiotherapy dis da
dtreatment dto dboost dor drestore dthe dability dof dthe dimmune dsystem dto

dfight dcancer, dinfections, dand dother ddiseases. d



It dis dalso dused dto dlessen dcertain dside deffects dthat dmay dbe dcaused dby
dsome dcancer dtreatments. d



Biological dtherapy dhelps dyour dimmune dsystem dfight dcancer dwhere
dchemotherapy dattacks dthe dcancer dcells ddirectly.




Candidates dfor dPROPHYLACTIC dFEEDING dTUBE dwith da dDIAGNOSIS dOF
dH&N dCANCER: d d d d d d d d dANSWER: d✔- dElderly dpatients



H&N dflap dreconstruction

Cancer dof dBOT

, Weight dLoss dbefore dcancer dtreatment

Smoking d>20 dcigarettes ddaily

Stage dIII dor dIV dcancer



Reference: dPage d22 din dthe dpocket dguide dto dthe dNCP dand dCancer



Common danti-nausea dmedications: d d d d d d d d dANSWER: d✔- dAprepitant
d(Emend®)



Dolasetron d(Anzemet®)

Granisetron d(Kytril®)

Ondansetron d(Zofran®)

Palonosetron d(Aloxi®)

Proclorperazine d(Compazine®)

Promethazine d(Anergan®), d(Phenergan®)

Netupitant-Palonosetron d(Akyzeo®)

Rolapitant d(Varubi®)

Lorazepam d(Ativan®)

Metoclopramide d(Reglan®)

Dexamethasone d(Decadron®)

Famotidine d(Pepcid®)

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller bonie314. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $11.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

81989 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$11.49
  • (0)
  Add to cart